NFE2L2 and lung carcinoma: In addition, recent evidence suggests that in mouse models of lung cancers, activated Nrf2 inhibits the Fbxo22-dependent degradation of Bach1 via induction of Ho-1 expression, and high levels of Bach1 promoting metastasis [33].